These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 31755312

  • 1. Design, synthesis of novel C-3'-N-sulfonyl modified taxane analogues from 1-deoxybaccatin VI and their impact on anti-HCC activity.
    Xiao YR, Cui YM, Xie CH, Qiu WQ, Lin HX.
    J Asian Nat Prod Res; 2020 Dec; 22(12):1168-1175. PubMed ID: 31755312
    [Abstract] [Full Text] [Related]

  • 2. Syntheses and biological evaluation of C-3'-N-acyl modified taxane analogues from 1-deoxybaccatin-VI.
    Li QF, Lin HX, Cui YM, Xu PP.
    Eur J Med Chem; 2015 Nov 02; 104():97-105. PubMed ID: 26448037
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of C-13, C-14 modified taxane analogues from 1-deoxybaccatin VI.
    Tang P, Lin HX, Yuan TH, Cui YM.
    Nat Prod Res; 2019 Dec 02; 33(24):3478-3484. PubMed ID: 29897250
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of novel A-seco-taxoids derived from 1-deoxybaccatin VI.
    Qiu WQ, Cui YM, Tang P, Qiu YY, Lin HX.
    Nat Prod Res; 2018 Jan 02; 32(2):121-127. PubMed ID: 28658975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. p-TSA-promoted syntheses of 5H-benzo[h] thiazolo[2,3-b]quinazoline and indeno[1,2-d] thiazolo[3,2-a]pyrimidine analogs: molecular modeling and in vitro antitumor activity against hepatocellular carcinoma.
    Keshari AK, Singh AK, Raj V, Rai A, Trivedi P, Ghosh B, Kumar U, Rawat A, Kumar D, Saha S.
    Drug Des Devel Ther; 2017 Jan 02; 11():1623-1642. PubMed ID: 28615927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    Eldehna WM, Fares M, Ibrahim HS, Aly MH, Zada S, Ali MM, Abou-Seri SM, Abdel-Aziz HA, Abou El Ella DA.
    Eur J Med Chem; 2015 Jul 15; 100():89-97. PubMed ID: 26071861
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma.
    Abou-Salim MA, Shaaban MA, Abd El Hameid MK, Elshaier YAMM, Halaweish F.
    Bioorg Chem; 2019 Apr 15; 85():515-533. PubMed ID: 30807895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study.
    Mok TS, Choi E, Yau D, Johri A, Yeo W, Chan AT, Wong C.
    Oncology; 2006 Apr 15; 71(3-4):292-6. PubMed ID: 17657173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.